How to attract investors for medical devices - Concrete advice from Private Investors and BII

Medtech Event for Start-ups and Investors

Why do many Medtech startups struggle to attract investors, and what makes an investor walk away from a promising medtech case?

Potential outputs from participating:

How to attract and communicate/pitch for investors
How to make good use of funding from investors to avoid valley of death
How investor funding and product development relates
How much funding is needed for reaching the market
Get insights into what Bioinnovation Institute is looking for

Join us to discuss what medical device startups can do to improve their attractiveness and how investors can improve their assessment process of medtech startup.

Thursday, March 20th from 4.30 pm to 7.00 pm

Event Details

Speakers:
1. Kristine Kuni Buccoliero, CEO & Founder of NeoCare Nordic, creating a product for neonatal care, Investee of multiple rounds from a variation of experienced and new Medtech investors.

2. Finn Ketler, Former VP of Woundcare, Coloplast, one medtech listing on First North, will elaborate on the private investor side having invested in several companies

3. Christian Hebel, Senior Associate at BioInnovation Institute’s Business Development team, will talk about what BII is looking for in Medtech Companies

Program:

16:00-16:30 – Arrival + Welcome Drink
16:30-18:15 – Speakers + Q&A Panel on theme
18:15-19:00 – Networking + Drinks & perhaps a chance to discuss

Location:
Vesterbrogade 26, Republikken, 1620 Copenhagen
Paid Parking – Saga P-hus, Vesterbrogade 23

The event is open for people with an interest in Medtech.

Theme Background

When only scratching the surface, investments in medtech look better than ever. The industry has seen the second greatest increase in VC funding post-covid* -reaching an all time high of €30 Billion invested in a year. However, a still smaller share is going to medtech startups**, while an ever growing number of these startups compete for it.

The great question is: Why isn’t more of the investments going to medtech startups?, when they are renowned for: addressing a need, having large market potential, and great scalability.

This is at least how medical device companies pitch it. The reasoning may be different through the eyes of investors, as medtech is also known for: ambiguity & uncertainty, slow adoption and long time to exit.

The above points call for a strategic funding approach from medtech startups and for educating investors to understand the value and difficulties of investing in this space.

Thus, the event will take offset in:

What can medtech startups do to attract investors?

What should investors look for in medtech startups?

Sources: *+63 %, only surpassed by pharma/biotech with +66 %
** Decline from 29 % to 23 % in five years New strategies for Medtech Startups. Attracting investment from across the innovation ecosystem, Deloitte, Advamed. Facts & Figures 2024, Medtech Europe